Aims and Scope of Melanoma Research
Melanoma Research (print: ISSN 0960-8931, online: ISSN 1473-5636) is a peer-reviewed medical journal published by Lippincott Williams & Wilkins since 1991. The journal publishes current findings on melanoma. Articles include both experimental and clinical research in a broad range of related subjects, including genetics, molecular biology, biochemistry, cell biology, photobiology, pathology, and immunology, and advances in clinical oncology influencing the prevention, diagnosis, and treatment of melanoma. Melanoma Research is published bimonthly. The current editor-in-chief is F.J. Lejeune. Less
Key Metrics
CiteScore 

6.7
Eigenfactor 

0.001 - 0.005
Impact Factor 

< 5
SJR 

Q2Oncology

SNIP 

0.88
Recommended pre-submission checks
Powered by 

Topics Covered on Melanoma Research
Melanoma Research Journal Specifications
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1991 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Melanoma Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Melanoma Research
E26 transformation-specific translocation variant 4 participates in melanoma progression and immune evasion by mediating the CD47molecule/signal regulatory protein α pathway.
- 27 Apr 2026
- Melanoma research
Expression and prognostic value of cyclase-associated proteins in cutaneous melanoma.
- 21 Apr 2026
- Melanoma research
Rapid hyperacute intracranial deterioration following initiation of ipilimumab/nivolumab in BRAF V600E-mutant melanoma of unknown primary with brain metastases after BRAF/MEK inhibitor therapy: a case series.
- 3 Apr 2026
- Melanoma research
Circulating tumor DNA accelerates diagnosis and treatment guidance for metastatic uveal melanoma with hepatic lesions not amenable to biopsy.
- 1 Apr 2026
- Melanoma research
Treatment effect of neoadjuvant immunotherapy in melanoma correlates with tumor burden: meta-analysis of reported clinical trials.
- 1 Apr 2026
- Melanoma research
Immune-related cholecystitis following combination therapy with nivolumab and ipilimumab in a patient with metastatic melanoma: a case report and literature review.
- 26 Mar 2026
- Melanoma research
E26 transformation-specific translocation variant 4 participates in melanoma progression and immune evasion by mediating the CD47molecule/signal regulatory protein α pathway.
- 27 Apr 2026
- Melanoma research
Expression and prognostic value of cyclase-associated proteins in cutaneous melanoma.
- 21 Apr 2026
- Melanoma research
Rapid hyperacute intracranial deterioration following initiation of ipilimumab/nivolumab in BRAF V600E-mutant melanoma of unknown primary with brain metastases after BRAF/MEK inhibitor therapy: a case series.
- 3 Apr 2026
- Melanoma research
Circulating tumor DNA accelerates diagnosis and treatment guidance for metastatic uveal melanoma with hepatic lesions not amenable to biopsy.
- 1 Apr 2026
- Melanoma research
Treatment effect of neoadjuvant immunotherapy in melanoma correlates with tumor burden: meta-analysis of reported clinical trials.
- 1 Apr 2026
- Melanoma research
Immune-related cholecystitis following combination therapy with nivolumab and ipilimumab in a patient with metastatic melanoma: a case report and literature review.
- 26 Mar 2026
- Melanoma research